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Background. Traumatic events are common globally; however, comprehensive population-based cross-national data on
the epidemiology of posttraumatic stress disorder (PTSD), the paradigmatic trauma-related mental disorder, are lacking.
Methods. Data were analyzed from 26 population surveys in the World Health Organization World Mental Health
Surveys. A total of 71 083 respondents ages 18+ participated. The Composite International Diagnostic Interview assessed
exposure to traumatic events as well as 30-day, 12-month, and lifetime PTSD. Respondents were also assessed for treat-
ment in the 12 months preceding the survey. Age of onset distributions were examined by country income level.
Associations of PTSD were examined with country income, world region, and respondent demographics.
Results. The cross-national lifetime prevalence of PTSD was 3.9% in the total sample and 5.6% among the trauma
exposed. Half of respondents with PTSD reported persistent symptoms. Treatment seeking in high-income countries
(53.5%) was roughly double that in low-lower middle income (22.8%) and upper-middle income (28.7%) countries.
Social disadvantage, including younger age, female sex, being unmarried, being less educated, having lower household
income, and being unemployed, was associated with increased risk of lifetime PTSD among the trauma exposed.
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Conclusions. PTSD is prevalent cross-nationally, with half of all global cases being persistent. Only half of those with
severe PTSD report receiving any treatment and only a minority receive specialty mental health care. Striking disparities
in PTSD treatment exist by country income level. Increasing access to effective treatment, especially in low- and middle-
income countries, remains critical for reducing the population burden of PTSD.
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Introduction
Trauma is common globally. In a comprehensive
report based on the World Mental Health (WMH)
Surveys, Benjet et al. (2016) found that 70% of the
populations in the countries studied reported exposure
to a traumatic event, with exposure ranging from 29%
in Romania to 83% in Peru. Although the majority of
trauma-exposed individuals respond with resilience,
a substantial minority go on to develop posttraumatic
stress disorder (PTSD), the cardinal trauma-related
mental disorder. PTSD often leads to very serious
interpersonal and occupational challenges, and has
been estimated to result in 3.6 days of lost productivity
per month (Kessler, 2000). The disorder has been called
a ‘life sentence’ due to its association with increased
risk of chronic disease, accelerated aging, and prema-
ture mortality (Boscarino, 2006; Kubzansky et al.
2007; Miller & Sadeh, 2014; Roberts et al. 2015).
Previous studies have shown that the lifetime preva-
lence of PTSD varies widely across countries (Breslau,
2009). Surveys that ask about the worst event (iden-
tified by respondents) generally find higher rates of
PTSD, ranging from 1.7% in South Korea (Jeon et al.
2007) to 9.2% in Canada (Van Ameringen et al. 2008),
than surveys that assess PTSD in relation to an unspe-
cified or random event, e.g. 2.3% in South Africa
(Atwoli et al. 2013), 2.5% in Iraq (Alhasnawi et al.
2009), and 3.4% in Lebanon (Karam et al. 2008). The
fact that prevalence estimates appear to vary widely
by country suggests that an accurate picture of the
worldwide prevalence of PTSD requires surveying
countries across the global using a consistent instru-
ment, sampling procedures, and analytic approach.
No previous report has brought together lifetime,
12-month, and 30-day PTSD prevalence across the
full range of countries available in the WMH Survey.
Lifetime prevalences provide an estimate of the pro-
portion of the population that develops PTSD.
Current or 12-month prevalences include both new
(incident) and persistent cases. The proportion of
12-month cases among lifetime cases is informative
as an indicator of persistent PTSD. However, 30-day
prevalences are valuable as they provide the true bur-
den of PTSD at a point in time. Moreover, 30-day pre-
valences are rarely reported because they require large
sample sizes for estimation. In fact, 30-day prevalences
have not previously been reported for WMH Survey
countries.
Despite the debilitating nature of PTSD, many peo-
ple with the disorder do not seek treatment, and even
then do so only after experiencing symptoms for
extended periods of time (Goldmann & Galea, 2014).
In the USA, where services are more available than in
most of the world (Roberts et al. 2011), only about
half of those with PTSD seek treatment and only 58%
of those seeking treatment receive care from a mental
health professional (Kessler, 2000). Relatively little is
known about treatment seeking by persons with
PTSD outside the USA and Western Europe.
Several reviews and meta-analyses have examined
correlates of PTSD, consistently finding that sociode-
mographic indicators of social disadvantage are asso-
ciated with the disorder (Brewin et al. 2000; Tolin &
Foa, 2006; Ozer et al. 2008). Younger age at the time
of trauma has been associated with increased risk of
developing PTSD (Brewin et al. 2000). Across a range
of types of trauma exposure, women are approxi-
mately twice as likely as men to be diagnosed with
PTSD (Tolin & Foa, 2006; Bangasser & Valentino,
2014). Individuals who have less social support, are
less educated, and are of lower socioeconomic status
are also more likely to be diagnosed (Brewin et al.
2000). However, the associations between demo-
graphic correlates and PTSD vary by study design
(e.g. prospective v. retrospective), study population
(e.g. civilian v. military) (Brewin et al. 2000), and coun-
try income level (Atwoli et al. 2015).
Moreover, few studies have examined sociodemo-
graphic correlates of PTSD persistence. Research on
other disorders has shown differing associations of
sociodemographic factors with disorder onset and
course. For example, in the USA racial/ethnic minority
status is associated with decreased risk of developing a
substance-related disorder, but increased risk of the
disorder is becoming chronic (Breslau et al. 2005).
Also in the USA, major depressive disorder is less
prevalent, but more likely to be chronic, among minor-
ity groups (Williams et al. 2007). For example, women
are at higher risk of lifetime depression, but sex is unre-
lated to course of depression (Kessler, 2003).
While a number of country-specific results on the
epidemiology of PTSD from the WMH Surveys have
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been published (Atwoli et al. 2013; Carmassi et al. 2014;
Ferry et al. 2014; Kawakami et al. 2014; Olaya et al.
2015), this is the first paper to bring together WMH
data cross-nationally in order to establish a global epi-
demiology of PTSD, including data on prevalence,
treatment seeking, and demographic correlates.
Specifically, this paper addressed four limitations of
previous research. First, no previous report has
brought together trauma exposure and PTSD preva-
lence rates across all the WMH Survey countries for
summary and comparison. Second, the WMH
Surveys addressed issues of study heterogeneity affect-
ing cross-national prevalence estimates by using stan-
dardized methods for sample selection and
assessment across all countries. Third, this report
examines disparities in treatment-seeking by country
income level. Fourth, this report examines whether
sociodemographic correlates, extensively documented
in the USA and European samples, are evident across
country income levels.
Methods
Sample
The 26 WMH Surveys were conducted in 24 countries,
18 of which were nationally representative and eight
that covered metropolitan areas with two surveys of
distinct regions in both Spain and Colombia. They
included four low-lower middle income countries, –
six upper-middle income countries, and 13 high
income countries as classified by the World Bank
with surveys fielded between 2001 and 2012 (see
online Supplemental Table S1). The surveys consisted
of face-to-face interviews conducted in two parts. In
part I of the interview, all respondents were evaluated
for core psychiatric disorders. Part II of the interview,
which assessed traumatic event (TE) exposure and
PTSD, was administered to the subsample of respon-
dents reporting any lifetime mental disorder as well
as a probability subsample of part I respondents.
Most surveys were composed of nationally representa-
tive household samples; several focused on all or select
urban areas within a country. Sociodemographic
information collected during interviews was used to
post-stratify survey responses to create a nationally
representative sample of each country with respect to
these variables. A total of 123 299 respondents com-
pleted part I of the interview and 71 083 completed
part II with an average response rate of 70.6% (range
45.9–97.2%). Institutional Review Boards at each
organization conducting a survey approved the study
and the informed consent procedure. A detailed
description of the WMH Surveys is reported elsewhere
(Heeringa et al. 2008).
Measures
The Composite International Diagnostic Interview
(CIDI) version 3.0 was used to assess TE exposure,
PTSD, and other psychiatric disorders according to
DSM-IV criteria (Kessler & Üstün, 2004). The CIDI
assessed 29 types of TEs across six categories: seven
war-related events (e.g. combatant, civilian in a war
zone), five types of physical assault (e.g. beaten by a
caregiver as a child, mugged), three types of sexual
assault (e.g. stalked, raped), six events involving
other threats to physical integrity (e.g. life-threatening
accidents, natural disasters), five events involving
threats to loved ones (e.g. life-threatening illness/
injury), and the traumatic death of loved one. In add-
ition, respondents were asked an open-ended question
about TEs not listed during the interview as well as
TEs that respondents did not wish to describe in detail.
Respondents were asked about both the number of life-
time occurrences and the age when each TE occurred
(Benjet et al. 2016). Missing values on TE reports
were assigned a value of ‘no’ and age of onset
(AOO) was imputed using a single imputation based
on the multiple imputation program in SAS 9.4.
Respondents reporting more than one qualifying type
of TE were assessed for PTSD twice: once for the self-
nominated worst lifetime TE and a second time for one
instance of a TE type randomly selected from all those
reported (Breslau & Kessler, 2001). The number of TEs
reported for the randomly selected TE was multiplied
across all TEs, which were then aggregated across
respondents and used to create a weighted dataset
that was representative of all lifetime TEs that occurred
to all respondents (Kessler & Üstün, 2004).
Respondents who experienced a qualifying TE (e.g.
met Criterion A1) were assessed for DSM-IV PTSD
Criteria B (re-experiencing), C (avoidance), and D
(hyperarousal) regardless of whether they met the A2
requirement (response to the TE involved intense
fear, helplessness or horror). Respondents meeting
Criteria B-D were then assessed for Criteria E (symp-
tom duration longer than 1 month) and F (clinically
significant distress or impairment).
Six measures of PTSD prevalence were estimated: (1)
prevalence of lifetime PTSD in the overall population,
(2) prevalence of lifetime PTSD among the trauma
exposed, (3) 12-month prevalence of PTSD among
the exposed, (4) 30-day prevalence of PTSD among
the exposed, (5) 12-month prevalence of PTSD
among lifetime cases, and (6) 30-day prevalence of
PTSD among 12-month cases. The 12-month and
30-day prevalence of PTSD among lifetime cases pro-
vide indirect estimates of both the reduction in PTSD
symptoms as well as the persistence among those
whose symptoms did not remit. Sociodemographic
2262 K. C. Koenen et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291717000708
Downloaded from https://www.cambridge.org/core. Aga Khan University - Kenya, on 10 Dec 2020 at 13:17:46, subject to the Cambridge Core terms of use, available at
variables were also assessed at the time of interview,
including age, gender, employment status (employed,
student, homemaker, retired, employed), marital status
(never married, divorced/separated/widowed, cur-
rently married), education level (no education, some
primary, finished primary, some secondary, finished
secondary, some college, finished college), and house-
hold income relative to national standards (low, low-
average, high-average, high).
Statistical analyses
Cross-tabulations were used to calculate prevalence
and treatment. Survival models were used to estimate
the associations of correlates with TE exposure and
with lifetime PTSD among the exposed, controlling
for age-cohort, gender, person-years, and country.
Associations between sociodemographic correlates
and 12-month PTSD among lifetime cases were esti-
mated using logistic regression controlling for time
since PTSD onset, age of PTSD onset, sex, and country.
Age of PTSD onset was defined separately within each
country with the 25% of PTSD cases (25th percentile)
with the earliest age were defined as early onset fol-
lowed by early-average (50th percentile), late-average
(75th percentile), and late onset. A continuous measure
of time since onset was created by subtracting age at
interview from the age when PTSD symptoms began.
Survival analysis was used to estimate AOO,
defined as the respondent’s age when they reported
starting to have symptoms, and projected lifetime
risk of PTSD. The actuarial method implemented in
SAS 9.4 was used to generate the AOO curves.
Significance was calculated using Wald and
McNemar’s χ2 tests. Because the data were weighted
and clustered, the Taylor series linearization method
implemented in the SUDAAN software package
(11.0) was used to estimate design-based standard
errors. Statistical significance was evaluated using two-
sided tests, with p < 0.05 considered significant.
Results
Prevalence
The prevalence of trauma exposure and the prevalence
of PTSD among the trauma exposed are presented in
Table 1. TE exposure prevalence rates previously
reported in Benjet et al. (2016) are included here to pro-
vide context for the PTSD data. The lifetime prevalence
of PTSD in the population was 3.9% with significant
variation across countries: High income countries
(5.0%) had twice the proportion of PTSD cases as
upper-middle income (2.3%) and lower-low middle
income countries (2.1%).
Among respondents who experienced a TE, the life-
time prevalence of PTSD was 5.6% and varied signifi-
cantly across countries, income groups, and World
Health Organization (WHO) regions, with lifetime
prevalence of PTSD higher among trauma-exposed
individuals in high-income countries (6.9%) than in
upper-middle income (3.9%), and low-lower middle
income countries (3.0%). A similar pattern was
observed for 12-month and 30-day prevalence among
the exposed. The 12-month prevalence among the
exposed was 2.8% and varied significantly by country
income, with the prevalence in high-income countries
(3.6%) more than twice that in upper-middle (1.6%)
and lower-low middle income countries (1.5%). The
30-day prevalence among the exposed was 1.4% and
varied significantly by country income, with the preva-
lence in high-income countries (1.9%) almost three
times that of upper-middle countries (0.7%) and lower-
low middle income countries (0.6%).
Twelve-month prevalence among the exposed also
varied across WHO regions, with the Western Pacific
region reporting a rate (4.3%) more than four times
the prevalence in the Africa region (1.0%). Thirty-day
prevalence among the exposed also varied across
WHO regions, with the Western Pacific region report-
ing a 30-day prevalence among the exposed (2.4%) that
was 12 times the prevalence in the Africa region (0.2%).
Symptom persistence and reduction
The 12-month prevalences among lifetime cases and
30-day prevalences of PTSD among 12-month cases
are presented in Table 2. The 12-month prevalence of
PTSD among lifetime cases, which is one indicator of
symptom persistence or reduction of PTSD among
respondents who ever develop the disorder, varied
by country, country income group, and WHO region.
The proportion of cases with persistent PTSD varied
widely across countries, even countries with similar
lifetime prevalence. For example, Belgium and
Lebanon had a similar lifetime prevalence of PTSD
among the exposed of 4.1% and 4.2% respectively.
However, the 12-month prevalence of PTSD among
the exposed in Lebanon was twice (2.4%) that of
Belgium’s (1.2%). As a result, Lebanon’s 12-month
prevalence of PTSD among lifetime cases (58.2%) was
more than twice that of Belgium’s (28.0%).
The 30-day prevalence among 12-month cases pro-
vides insight into how the duration of PTSD varies
across countries. Of note, the 30-day prevalence of
PTSD among 12-month cases varied significantly by
country and WHO region, but not by country income.
Again using the example of Lebanon and Belgium,
Lebanon’s 30-day prevalence of PTSD among the
exposed (1.5%) was five times that of Belgium (0.3%).
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Table 1. Prevalence of DSM-IV posttraumatic stress disorder (PTSD) in the World Mental Health surveys (N = 71 083)
Country
Lifetime prevalence of
PTSD in total sample Trauma exposure
Lifetime prevalence of
PTSD among exposed
12-month prevalence of
PTSD among exposed
30-day prevalence of
PTSD among exposed
Sample
size usedn % S.E. n % S.E. N % S.E. n % S.E. n % S.E.
Low-lower middle income countries 394 2.1 0.2 8530 69.1 0.7 394 3 0.2 198 1.5 0.2 95 0.6 0.1 11 862
Colombia 58 1.8 0.4 2068 82.7 1.4 58 2.2 0.5 25 0.7 0.2 6 0.2 0.1 2381
Iraq 140 2.5 0.2 2458 56 0.8 140 4.4 0.4 61 2 0.3 23 0.7 0.2 4332
Peru 22 0.7 0.1 1530 83.1 0.8 22 0.8 0.2 7 0.2 0.1 2 0.1 0.1 1801
PRC China 11 0.3 0.1 929 52.5 2.6 11 0.5 0.2 8 0.4 0.2 2 0.1 0.1 1628
Ukraine 163 4.8 0.6 1545 84.6 1.7 163 5.7 0.7 97 3.4 0.6 62 2 0.4 1720
Upper-middle income countries 602 2.3 0.1 11 266 63.2 0.6 602 3.6 0.2 273 1.6 0.1 116 0.7 0.1 16 913
Brazil 160 3.2 0.2 2330 73.8 1.5 160 4.3 0.3 81 2.1 0.3 35 0.9 0.2 2942
Bulgaria 73 1.9 0.3 776 28.6 1.3 73 6.5 1.1 45 4 0.6 27 2.8 0.6 2233
Colombia (Medellin) 109 3.7 0.6 1387 75.1 2.6 109 4.9 0.8 39 1.3 0.3 9 0.3 0.1 1673
Lebanon 70 3.4 0.6 873 81.1 2.7 70 4.2 0.7 30 2.4 0.8 16 1.5 0.7 1031
Mexico 68 1.5 0.3 1818 68.8 1.8 68 2.1 0.4 29 0.8 0.2 15 0.3 0.1 2362
Romania 31 1.2 0.3 997 41.5 1.1 31 2.8 0.7 16 1.8 0.6 6 0.9 0.4 2357
South Africa 91 2.3 0.3 3085 73.8 1.2 91 3 0.4 33 1 0.2 8 0.2 0.1 4315
High income countries 3107 5 0.1 32 001 72.4 0.4 3107 6.9 0.2 1615 3.6 0.1 817 1.9 0.1 42 308
Australia 640 7.3 0.4 6519 76.2 0.7 640 9.6 0.5 382 5.8 0.3 216 3.3 0.3 8463
Belgium 51 2.7 0.5 710 65.8 3.1 51 4.1 0.8 22 1.2 0.2 9 0.3 0.1 1043
France 98 3.9 0.6 1071 72.7 2.3 98 5.4 0.7 58 3.2 0.6 23 1.4 0.4 1436
Germany 54 1.7 0.3 928 67.3 2.2 54 2.5 0.5 25 1 0.2 11 0.4 0.2 1323
Israel 73 1.6 0.2 3679 74.8 0.7 73 2.1 0.3 25 0.8 0.2 10 0.3 0.1 4859
Italy 65 2.4 0.6 1064 56.1 2.2 65 4.3 1 25 1.3 0.4 11 0.6 0.2 1779
Japan 38 1.3 0.2 1138 60.7 1.7 38 2.1 0.4 19 1.2 0.3 6 0.4 0.2 1682
New Zealand 828 6.1 0.3 6089 79.3 0.8 828 7.6 0.4 416 3.8 0.3 218 2.1 0.2 7312
Northern Ireland 238 8.8 0.7 1287 60.6 1.7 238 14.5 1.1 129 8.4 0.9 61 4 0.7 1986
Portugal 180 5.3 0.5 1548 69 1.7 180 7.7 0.7 77 3.3 0.5 32 1.4 0.3 2060
Spain 85 2.2 0.4 1284 54 1.7 85 4 0.8 35 1 0.2 16 0.3 0.1 2121
Spain (Murcia) 65 2.8 0.5 942 62.4 1.9 65 4.5 0.7 26 1.4 0.4 16 0.7 0.1 1459
The Netherlands 90 4.4 0.8 788 65.6 2.8 90 6.7 1.2 50 4.1 1.1 27 1.6 0.5 1093
The USA 602 6.9 0.4 4954 82.7 0.9 602 8.3 0.5 326 4.3 0.3 161 2.1 0.2 5692
All countries combined 4103 3.9 0.1 51 797 69.7 0.3 4103 5.6 0.1 2086 2.8 0.1 1028 1.4 0.1 71 083
WHO regionsa
Region of the Americas 1019 3.8 0.2 14 087 78.5 0.6 1019 4.8 0.2 507 2.2 0.1 228 1 0.1 16 851
African Region 91 2.3 0.3 3085 73.8 1.2 91 3 0.4 33 1 0.2 8 0.2 0.1 4315
Western Pacific Region 1517 5.7 0.2 14 675 74 0.5 1517 7.7 0.3 825 4.3 0.2 442 2.4 0.2 19 085
2264
K
.C
.K
oenen
et
al.
https://w
w
w
.cam
bridge.org/core/term
s. https://doi.org/10.1017/S0033291717000708
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core. Aga Khan U
niversity - Kenya, on 10 D
ec 2020 at 13:17:46, subject to the Cam
bridge Core term
s of use, available at
In other words, PTSD was five times more likely to
persist over the year in Lebanon than in Belgium. In
summary, Lebanon had a higher burden of PTSD
than Belgium at the time of the survey, even though
lifetime prevalence of PTSD among the exposed was
similar across the two countries.
Age of onset
Cumulative distributions for the age of PTSD onset
stratified by county income group are presented in
Fig. 1. Onset of PTSD was earlier on average in high
income countries than in low-lower and upper-middle
income countries, with half of high income countries’
respondents reporting PTSD onset before age 30 com-
pared with age 43 for low-lower income countries. In
high income countries, 30% of respondents reported
PTSD onset before age 18 compared with fewer than
16% in upper-middle income and 10% in low-lower
income countries. Across all groups, the vast majority
of respondents reported symptoms beginning immedi-
ately after the TE.
Treatment
Fewer than half of respondents with 12-month PTSD
reported seeking any type of treatment (see Table 3).
Individuals in high income countries were approxi-
mately twice as likely to seek treatment (53.5%) as
those in low-lower middle income (22.8%) and upper-
middle income countries (28.7%). These disparities
were observed across all treatment sectors. The one
exception was the human services sector – including
religious or spiritual advisors, social workers, and
counselors – where treatment was sought less in
upper-middle income countries (2.5%) than in low-
lower income (7.1%) and high income countries
(7.0%). While a quarter of respondents with PTSD
reported seeking specialty mental health treatment in
the 12 months before interview (see Fig. 2), there
were substantial differences across country income
groups, with only 3.2% of respondents in low-lower
income countries receiving treatment compared with
28.7% in high income countries.
Sociodemographic correlates
Table 4 presents associations between sociodemo-
graphic correlates and TE exposure, lifetime PTSD
among the exposed, and 12-month PTSD among life-
time cases in all countries. Sociodemographic results
for TE exposure are presented for reference; the reader
is referred to Benjet et al. (2016) for a detailed presenta-
tion and discussion (Benjet et al. 2016).All sociodemo-
graphic correlates were significantly associated with a
lifetime diagnosis of PTSD among the trauma exposed.
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Respondents who were younger, female, not
employed, not currently married, less educated, and
having a lower household income were more likely
to develop PTSD. However, female sex, marital status,
and education level were not significantly associated
with persistence defined as 12-month PTSD among
lifetime cases. In addition, all household income cat-
egories below the highest income level were associated
Table 2. Prevalence of Persistent DSM-IV posttraumatic stress disorder (PTSD) in the World Mental Health surveys (N = 71 083)
12-month prevalence of PTSD
among lifetime cases
30-day prevalence of PTSD
among 12-month cases Sample
size
usedCountry n % S.E. n % S.E.
Low-lower middle income countries 198 47.8 3.9 95 43.2 5.4 11 862
Colombia 25 34.2 9.6 6 29.2 13.7 2381
Iraq 61 46.1 6.2 23 33.7 9.4 4332
Peru 7 23.1 8.9 2 37.5 26.1 1801
PRC China 8 82.1 11.5 2 17.9 14 1628
Ukraine 97 58.9 5.3 62 59.2 7.5 1720
Upper-middle income countries 273 43.5 2.7 116 44.3 4.5 16 913
Brazil 81 48.8 4.9 35 44.8 8.4 2942
Bulgaria 45 61.9 4.9 27 69.3 10.4 2233
Colombia (Medellin) 39 26.4 5.3 9 26.9 9.2 1673
Lebanon 30 58.2 11.2 16 62.3 12.6 1031
Mexico 29 39.2 8.6 15 40.3 11.9 2362
Romania 16 64.6 8.7 6 47.7 14.1 2357
South Africa 33 31.7 5.5 8 20 7.4 4315
High income countries 1615 52.1 1.2 817 51.3 1.8 42 308
Australia 382 60 2.2 216 56.6 3.3 8463
Belgium 22 28 6.2 9 29.7 9.5 1043
France 58 59.5 6.8 23 44.8 8 1436
Germany 25 40.9 8.3 11 36.9 11.5 1323
Israel 25 37.3 5.9 10 44.1 10.3 4859
Italy 25 30 7.6 11 48.8 13.1 1779
Japan 19 55.4 7.1 6 35 14 1682
New Zealand 416 50 2.5 218 54.9 3.8 7312
Northern Ireland 129 57.5 3.8 61 48 6.4 1986
Portugal 77 42.6 4.5 32 42.3 6.5 2060
Spain 35 26.1 6.7 16 33.5 9 2121
Spain (Murcia) 26 32.1 8.5 16 47.4 9.5 1459
The Netherlands 50 62 8.3 27 39.3 10.8 1093
The USA 326 52.4 2.9 161 49.3 4.1 5692
All countries combined 2086 50.5 1 1028 49.8 1.6 71 083
WHO regionsa
Region of the Americas 507 46.9 2.2 228 45.9 3.3 16 851
African Region 33 31.7 5.5 8 20 7.4 4315
Western Pacific Region 825 56 1.6 442 55.3 2.5 19 085
Eastern Mediterranean Region 116 44.9 4.2 49 42.6 6.7 10 222
Western European Region 447 46.7 2.3 206 44.1 3.3 14 300
Eastern European Region 158 60.7 3.6 95 59.8 5.7 6310
Comparison between countriesb χ225 = 4.0*, p < 0.001 χ
2
25 = 1.7*, p = 0.021
Comparison between low, middle and
high income country groupsb
χ22 = 4.3*, p = 0.013 χ
2
2 = 1.8, p = 0.158
Comparison between WHO regionsb χ25 = 7.1*, p < 0.001 χ
2
5 = 4.1*, p = 0.001
aRegion of the Americas (Colombia, Mexico, Brazil, Peru, The United States, Medellin); African region (South Africa); Western
Pacific region (PRC Beijing and Shanghai, Japan, Australia,New Zealand); Eastern Mediterranean region (Israel, Iraq, Lebanon);
Western European region (Belgium, France, Germany, Italy, The Netherlands, Spain, Northern Ireland, Portugal, Murcia);
Eastern European region (Romania, Bulgaria, Ukraine).
b χ2 test of homogeneity to determine if there is variation in prevalence estimates across countries.
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Fig. 1. Age of onset distributions of DSM-IV posttraumatic stress disorder by income-group countries.
Table 3. Among those with 12-month DSM-IV posttraumatic stress disorder, percent reporting treatment in the past 12 months (N = 71 083)
Treatment sector
Low-lower middle
income countries
Upper-middle
income countries
High income
countries
All countries
combined
Comparison
between countriesa% S.E. % S.E. % S.E. % S.E.
Specialty mental healthb 3.2 1.9 11.8 2.7 28.7 1.6 25.3 1.3 χ2 = 27.8*, p < 0.001
General medicalc 14.5 4.5 16.8 3.9 36.0 1.7 32.4 1.5 χ2 = 15.6*, p < 0.001
Health cared 16.8 4.6 24.6 4.3 49.3 1.8 44.4 1.6 χ2 = 23.6*, p < 0.001
Human servicese 7.1 2.2 2.5 1.2 7.0 0.9 6.4 0.8 χ2 = 4.3*, p = 0.01
CAMf − − 4.2 2.1 9.9 1.0 8.8 0.9 χ2 = 12.3*, p < 0.001
Non health careg 7.6 2.2 6.6 2.4 14.7 1.2 13.3 1.0 χ2 = 6.4*, p < 0.001
Any treatmenth 22.8 5.5 28.7 4.6 53.5 1.8 48.8 1.6 χ2 = 19.9*, p < 0.001
*p < 0.001.
a χ2 test of homogeneity to determine if there is variation in prevalence of treatment estimates across countries. χ2 test is
only generated where there is more than one stable cell (>=5 cases).
b The mental health specialist sector, which includes psychiatrist and non-psychiatrist mental health specialists (psychiatrist,
psychologist or other non-psychiatrist mental health professional; social worker or counselor in a mental health specialty set-
ting; use of a mental health helpline; or overnight admissions for a mental health or drug or alcohol problems, with a pre-
sumption of daily contact with a psychiatrist).
c The general medical sector (general practitioner, other medical doctor, nurse, occupational therapist or any healthcare
professional).
d The mental health specialist sector or the general medical sector.
e The human services sector (religious or spiritual advisor or social worker or counselor in any setting other than a specialty
mental health setting).
f The CAM (complementary and alternative medicine) sector (any other type of healer such as herbalist or homeopath, par-
ticipation in an internet support group, or participation in a self-help group).
g The human services sector or CAM.
h Respondents who sought any form of professional treatments listed in the footnotes above.
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with lifetime PTSD, but only the lowest income cat-
egory was associated with persistent PTSD. Being a
homemaker, retired, or ‘other’ employment status
were associated with an increased risk of lifetime
PTSD compared with being employed, but only an
employment status of ‘other’ was associated with per-
sistent PTSD.
Sociodemographic results by country income level
are presented in online Supplemental Tables S2–S4.
Results were largely consistent for lifetime PTSD
among the exposed across income level with three dif-
ferences. First, lower education was not associated
with PTSD prevalence in upper-middle income coun-
tries, but was associated in the low-lower and high
income country groups. Second, younger respondents
were not more likely to develop PTSD in low-lower
income and upper-middle income country groups.
Third, there were no significant differences by employ-
ment status for the risk of PTSD in the low-lower and
upper-middle income country groups although ‘other’
employment was still associated with PTSD onset in
the upper-middle income country group. For
12-month PTSD among lifetime cases, sociodemo-
graphic results differed markedly between the high
income country group and the other two groups. No
sociodemographic variables were associated with per-
sistent PTSD in the low-lower and upper-middle
income country groups. In contrast, having lower
household income, ‘other’ employment status, and
being divorced, separated, or widowed were asso-
ciated with more persistent PTSD in the high income
country group.
Discussion
Study limitations
The WMH Surveys have four limitations with particu-
lar relevance for interpreting results about trauma
exposure and PTSD. First, substantial variation in the
response rate across countries (45.9–97.2%) may lead
to bias if trauma or other sociodemographic variables
affected the likelihood of non-response. To account
for possible non-response bias, we used collected
sociodemographic information and population data
to post-stratify each country’s sample to be representa-
tive of the population. Second, TE exposure and PTSD
were assessed retrospectively, which may have led to
underreporting of lifetime TE exposure and PTSD or
misestimation of AOO. Third, while the WMH surveys
used the same assessment in all countries, cultural dif-
ferences may have affected respondents’ willingness to
discuss sensitive issues, especially stigmatizing TEs.
We attempted to mitigate underreporting by including
an open-ended question on TEs that respondents did
not want to describe, which was endorsed by 6.1% of
the total sample. Fourth, the WMH Surveys did not
include many countries with recent mass violence
and armed conflict. The limited data available suggest
that rates of PTSD are much higher rates in communi-
ties exposed to mass violence [e.g. lifetime PTSD
prevalence rates of 37.4% in Algeria (De Jong et al.
2001)].
Study strengths and notable findings
Despite these limitations, the WMH Surveys have sev-
eral strengths. First, these surveys assessed a large
sample within each country, two-thirds of which
were nationally representative. Their samples were
sufficiently large to permit estimates of 30-day preva-
lence in addition to 12-month and lifetime prevalence
of PTSD. For many countries, these are the first pub-
lished 30-day prevalence estimates of PTSD, providing
important information on the burden of PTSD. An
additional strength was the use of standardized mea-
sures to assess TEs and PTSD across all countries.
Our use of uniform questions mitigates differences
due to variation in wording and operationalization of
traumatic experiences and reactions. In addition, we
collected detailed, standardized demographic informa-
tion for all respondents, enabling us to examine the
associations of individual- and social-level factors
with PTSD prevalence and persistence.
Four notable findings merit discussion. First, we
found that 5.6% of respondents who were exposed to
trauma had a lifetime diagnosis of PTSD, with preva-
lence ranging from 0.5% to 14.5% across countries,
which may stem from variation in TE types across
Fig. 2. Percentage of respondents reporting specialty mental
health treatment by country income level.
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Table 4. Bivariate associations between sociodemographic correlates and DSM-IV posttraumatic stress disorder (PTSD) among trauma
exposed (all countries combined N = 71 083)
Correlates Exposure to TEa,f Lifetime PTSD among exposeda,f 12-month PTSD among lifetime casesb
OR (95% CI) OR (95% CI) OR (95% CI)
Age-cohort
18–29 2.0* (1.9–2.1) 2.5* (2.1–3.0)
30–44 1.6* (1.5–1.6) 2.1* (1.8–2.4)
45–59 1.3* (1.2–1.3) 1.8* (1.6–2.1)
60+ 1.0 1.0
Age-cohort differencec χ23 = 1063.8*, p < 0.001 χ23 = 122.1*, p < 0.001
Age of onsetd
Early 1.1 (0.9–1.5)
Early-average 0.8* (0.6–1.0)
Late-average 0.7* (0.5–0.9)
Late 1.0
Age of onset differencec χ23 = 21.7*, p < 0.001
Time since onset (Continuous) 0.97* (0.97–0.98)
χ21 = 62.0*, p < 0.001
Gender
Female 0.9* (0.8–0.9) 2.6* (2.4–2.9) 1.1 (0.9–1.3)
Male 1.0 1.0 1.0
Gender differencec χ21 = 146.0*, p < 0.001 χ21 = 321.8*, p < 0.001 χ21 = 0.5, p = 0.477
Employment status
Student 1.0 (0.9–1.1) 1.0 (0.7–1.3) 1.7 (1.0–3.0)
Homemaker 0.9* (0.8–0.9) 1.2* (1.0–1.4) 1.2 (0.9–1.6)
Retired 1.0 (0.9–1.1) 1.3* (1.1–1.6) 1.1 (0.8–1.5)
Other 1.1* (1.0–1.1) 1.7* (1.5–2.0) 1.5* (1.2–1.9)
Employed 1.0 1.0 1.0
Employment status differencec χ24 = 39.2*, p < 0.001 χ
2
4 = 77.7*, p < 0.001 χ
2
4 = 12.3*, p = 0.015
Marital status
Never married 1.0 (1.0–1.0) 1.3* (1.1–1.5) 1.1 (0.8–1.4)
Divorced/separated/widowed 1.2* (1.1–1.2) 1.7* (1.5–1.9) 1.2 (1.0–1.5)
Currently married 1.0 1.0 1.0
Marital status differencec χ22 = 67.2, p < 0.001 χ
2
2 = 70.8*, p < 0.001 χ
2
2 = 3.8, p = 0.152
Education level
No education 0.7* (0.6–0.8) 1.5 (0.9–2.7) 0.6 (0.3–1.2)
Some primary 0.9* (0.8–0.9) 1.4* (1.2–1.8) 1.0 (0.7–1.5)
Finished primary 0.9* (0.8–0.9) 1.7* (1.3–2.1) 1.2 (0.8–1.8)
Some secondary 1.0 (0.9–1.0) 1.4* (1.2–1.6) 0.9 (0.7–1.2)
Finished secondary 1.0 (1.0–1.0) 1.1 (0.9–1.3) 1.1 (0.8–1.5)
Some college 1.1* (1.0–1.1) 1.1 (0.9–1.3) 1.1 (0.8–1.5)
Finished college 1.0 1.0 1.0
Education level differencec χ26 = 85.7, p < 0.001 χ26 = 36.9*, p < 0.001 χ26 = 5.8, p = 0.447
Household income
Low 0.9* (0.9–1.0) 1.7* (1.5–1.9) 1.5* (1.2–1.9)
Low-average 1.0 (0.9–1.0) 1.5* (1.3–1.7) 1.3 (1.0–1.7)
High-average 1.0 (1.0–1.0) 1.4* (1.3–1.7) 1.0 (0.8–1.3)
High 1.0 1.0 1.0
Household income differencec χ23 = 13.3*, p = 0.004 χ
2
3 = 55.2*, p < 0.001 χ
2
3 = 15.8*, p = 0.001
Ne 1 646 308 1 310 008 4103
*Significant at the 0.05 level, 2 sided test.
a These estimates are based on survival models adjusted for age-cohorts, gender, person-years and country.
b These estimates are based on logistic regressionmodels adjusted for time since PTSD onset, age of PTSD onset, gender and
country.
c χ2 test of significant differences between blocks of sociodemographic variables.
d Defined in terms of within-survey quartiles of the age-of-onset distribution.
e Denominator N: 71 083 = total sample; 1 646 308, 1 310 008 and 30 67 607 = number of person-years in the survival models;
4103 = number of lifetime cases of PTSD.
f Iraq is not included into the analysis related to exposure to traumatic events (TEs) because the age of first exposure to TEs
is not available in Iraq. Excluding Iraq, there were 49 339 people exposed to TEs and 3963 people with PTSD.
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countries. Liu et al. (2017) found that PTSD prevalence
was associated with type of TE and that interpersonal
TEs (e.g. sexual violence) conferred an increased risk
for PTSD onset (Liu et al. 2017). Half of respondents
with the lifetime disorder had symptoms in the last
12 months, and almost half of 12-month cases reported
symptoms in the 30 days before interview, suggesting
a high level of symptom persistence. It is likely that at
least some participants with and without 30-day PTSD
experienced relapsing and remitting symptoms over
the year, a course of PTSD that has been documented
in several longitudinal studies (Osenbach et al. 2014;
Bryant et al. 2015). The DSM system, however, does
not distinguish between those who fully remit and
those whose symptoms are sensitive to flaring up
again with reminders. Consequently, the 30-day preva-
lence of PTSD, which represents the burden of PTSD at
the specific time the survey was conducted, may
underestimate the burden of PTSD if participants
symptoms had waned and were below the threshold
for a formal PTSD diagnosis at the time of interview,
but were still in distress. Similarly, the burden of
PTSD may be overestimated if symptoms were waxing
at the time of interview leading to more individuals
meeting formal diagnostic criteria than otherwise
would.
Second, our findings are also among the first reports
of treatment seeking for PTSD in countries outside of
the USA and Western Europe. Across all countries,
only half of all respondents reported seeking any
type of treatment. We found that respondents in high
income countries were almost twice as likely to seek
treatment as those in low-lower middle and upper-
middle income countries. These results broaden the
findings from a previous WMH report of 15 countries,
which found significant variation in treatment during
the year of disorder onset with 0.8% to 36.4% of
respondents reporting treatment for anxiety disorders
and a median delay of 3–30 years before treatment con-
tact (Wang et al. 2007).
Third, our results confirm earlier reports that PTSD
onset occurs later than in life than other anxiety and
mood disorders (Kessler et al. 2005; Kessler et al.
2007). However, we found wide variation in age of
onset across countries and income groups, with
PTSD developing significantly earlier in high income
countries (median age 25–28) compared with low-
lower middle (median age 43) and upper-middle
income countries (median age 30). Interestingly, the
relatively late AOO of PTSD contrasts with an earlier
WMH report showing that incident TE exposure is
more common among children, adolescents, and
young adults than among older individuals (Benjet
et al. 2016). While this may imply that conditional
risk for developing PTSD is higher in older adults
exposed to trauma, results presented in Table 4 show
that younger respondents were at greater risk for
developing PTSD. One possible reason for this discrep-
ancy may be that younger people are more likely to be
exposed to the types of TEs that have greater risk for
the development of PTSD. Exploring this issue is
beyond the scope of this chapter but we plan to
address it in future analyses of WMH data.
Fourth, we also examined sociodemographic corre-
lates of PTSD prevalence and persistence. We found
that lifetime PTSD among the exposed was associated
with being younger, female, not employed, not cur-
rently married, having a lower education level, and a
lower household income. These results were mostly
consistent across country income groups. Moreover,
our results for female sex are consistent with a large lit-
erature on sex differences in risk for PTSD (Tolin &
Foa, 2006). Only income level and employment status
were associated with persistent PTSD in the overall
sample. When countries were stratified by country
income, no sociodemographic variables were corre-
lated with persistent PTSD in the low-lower middle
and upper-middle country groups, whereas lower
socioeconomic status was associated with persistent
PTSD in the high income country group. Given lack
of information on the temporal ordering of sociodemo-
graphic factors and PTSD onset, we cannot determine
whether factors such as marital status or socio-
economic status are risk factors for, or consequences
of, the disorder.
Conclusions
The WMH Surveys show that half of PTSD cases are
persistent and that, among respondents reporting
PTSD symptoms in the last 12 months, only half
received any type of treatment. The gap in treatment
is even larger in low-lower middle income countries
and upper-middle income countries, where only a
quarter of respondents reported any kind of treatment.
Our results suggest at least two targets for intervention.
The first is to reduce the psychological sequelae of
trauma by early identification of those at risk for the
disorder. PTSD symptoms typically begin shortly
after TE exposure and evolve with time to either per-
sistence or recovery. PTSD is one of the most prevent-
able mental disorders, as many people exposed to TEs
come to clinical attention in first response settings such
as emergency rooms, intensive care units, and trauma
centers. Controlled clinical trials show that PTSD risk
can be significantly reduced by early preventive inter-
ventions (Foa et al. 1995; Kearns et al. 2012; Shalev et al.
2012). However, these interventions have nontrivial
costs, making it infeasible to offer them to all persons
exposed to TEs given that only a small minority goes
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on to develop PTSD (Kessler et al. 1995; Kessler, 2000;
Roberts et al. 2010). They are also unnecessary for
many survivors who recovery spontaneously (Shalev
et al. 2012). To be cost-effective, risk prediction rules
are needed to identify, which exposed persons are at
high risk of PTSD taking into consideration that pre-
dictors may vary between samples (Andrews et al.
2000; Brewin et al. 2000; Brewin, 2005; Roberts et al.
2011), within samples (e.g. between male and female
survivors), and at different time lags from the TE
(Shalev et al. 1997; Freedman et al. 1999). Data-driven
methods such as machine learning have shown prom-
ise in identifying persons at high risk for developing
PTSD (Kessler et al. 2014). However, large-scale pro-
spective studies of trauma survivors are needed to
develop predictive algorithms that can be widely
used. One such study has just been initiated by the
National Institutes of Mental Health.
A second strategy is to improve the identification
and access to treatment for persons with PTSD. The
low reported rates of treatment seeking was striking
across all country income levels but particularly so
among the low-lower middle and upper-middle
income countries, where treatment has been shown
to be effective (Bass et al. 2013). Screening for trauma
and PTSD in primary care may improve identification
and aid in treatment referral. Health care organizations
such as Kaiser Permanente have launched major
trauma informed care initiatives toward this goal
(Sharp, 2015). Moreover, treatment of PTSD in primary
settings has been shown to be effective (Roy-Byrne
et al. 2010). However, major efforts to such as PRIME
(program for improving mental health care), which is
focused on improving mental health care in several
low and middle income countries through integration
with maternal and primary care have not, to date,
included PTSD as a target disorder (Lund et al. 2012).
Thus, much work remains to be done with regard to
policy, research and treatment to address issues of
access to care and decrease the global burden of PTSD.
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